Drug delivery system for accelerated subcutaneous absorption
View Patent ↗A method for accelerating subcutaneous absorption of a fluid or drug into the systemic circulation of a specific targeted tissue. A first drug operative to produce local capillary vasodilatation and/or increase the rate of bulk flow of solution through the interstitial space is mixed with a fluid. The fluid may contain a crystalloid solution or a dilute solution of a pharmacologic drug required for a routine or emergency therapeutic treatment for a patient. The first drug is substantially non-toxic to the patient. The fluid mixed with the first drug is then delivered subcutaneously or into deeper tissues of the patient, by use of a hyperdermic needle or infiltration cannula. As the capillaries are dilated, the fluid is efficiently absorbed and circulated systemically.
1. A drug delivery method comprising:
a) dissolving methyl-nicotinamide or methyl-nicotinate at a substantially non-toxic concentration with a fluid solvent, wherein the methyl-nicotinamide or methyl-nicotinate is operative to produce local capillary vasodilation; and
b) subcutaneously or intramuscularly applying the fluid containing the first drug to a patient.
2. The method of claim 1 , wherein fluid includes physiologic saline.
3. The method of claim 1 , wherein the fluid includes a dilute solution of local anesthetic.
4. The method of claim 1 , wherein the fluid includes a dilute solution of lidocaine.
5. The method of claim 1 , wherein step (b) includes applying the fluid containing the first drug by subcutaneous infiltration.
6. The method of claim 5 , wherein step (b) includes:
b1) inserting an infiltration cannula under skin of the patient; and
b2) infiltrating the fluid containing the first drug into subcutaneous tissue or muscle of the patient through the infiltration cannula.
7. The method of claim 6 , wherein step (b1) includes inserting a plastic infiltrator under the skin of the patient.
8. The method of claim 1 , further comprising the step of:
c) applying a solution of a vasoconstrictive drug operative to cause vasoconstriction of cutaneous blood vessels of the patient.
9. The method of claim 8 , wherein the vasoconstrictive drug includes a solution of epinephrine.
10. The method of claim 1 , wherein the fluid contains a second drug for treating a subcutaneous tissue of the patient.